Navigation Links
Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
Date:10/29/2008

SAN MARINO, Calif., Oct. 29 /PRNewswire/ -- Epeius Biotechnologies Corporation announced today the expansion of clinical trials using intravenous Rexin-G for pancreatic cancer and breast cancer in Manhattan, New York. Rexin-G is the world's first tumor-targeted genetic medicine that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body. Clinical data from on-going studies in Los Angeles, California, indicating dose-dependent tumor control rates and survival benefits with no major toxicity in Rexin-G-treated patients prompted the extension of these clinical trials to the East Coast. Rexin-G has gained orphan drug status from the U.S. FDA for three clinical indications: pancreatic cancer, osteosarcoma and soft tissue sarcoma.

The New York clinical trials will be conducted at the Bruckner Oncology Center in Manhattan, New York with Howard W. Bruckner, M.D. as the Principal Investigator. Dr. Bruckner is a board certified medical oncologist who trained at Yale University School of Medicine and performed research at the NIH with specialists and collaborative groups. Dr. Bruckner is internationally renowned for his work in pancreatic, breast, gastrointestinal, colon, and ovarian cancers and was the first medical oncologist to treat patients with Rexin-G for advanced pancreatic cancer in the United States (Int'l J Oncol 2006). He has served as an Expert Consultant and Safety Monitor for the National Surgical Adjuvant Project for Breast and Bowel Cancers Project (NSABP) sponsored by the National Cancer Institute. For further information concerning these clinical trials in New York, please go to http://www.clinicaltrials.gov and search Epeius-sponsored protocols C07-104 and C07-105.

About Epeius Biotechnologies

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic
'/>"/>

SOURCE Epeius Biotechnologies Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
2. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
3. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
4. ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
5. MEDICA 2008 Returns in November
6. NanoMedicine Summit Returns to Cleveland, September 25-26
7. Cystic Fibrosis Trial In Children Returns Positive Data
8. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
9. Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
10. Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment
11. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , Sept. 15, 2014  The second annual ... celebrated October 12-18. A joint initiative of the ... member companies , IPAW is designed to: ... , Recognize the contributions of plasma donors in saving ... plasma protein therapies and rare diseases ...
(Date:9/13/2014)... 13, 2014 Boehringer Laboratories Inc., with ... proud to announce the successful broadcast of a live ... Leonardo Claros, MD, FACS, FAMBS, and Maher El Chaar, ... Calibration System. , This sleeve gastrectomy surgery was ... more than four hundred surgeons from around the world ...
(Date:9/12/2014)... Nasa Ames Research Base, Mountain View, CA (PRWEB) September ... announces the launch of its fundraising campaign on Indiegogo. ... producer Matt Rutherford, features Stephen Hawking, Buzz Aldrin, Shimon ... , Exponential technology is changing the world and there’s ... students how to harness it to help change the ...
(Date:9/11/2014)... Berkeley Lab researchers believes it has uncovered the ... atomic layers of transition metal dichalcogenide (TMDC) materials, ... nanoelectronic and photonic applications. , Using two-photon ... disulfide, one of the most promising of 2D ... excitonic dark states energy states in which ...
Breaking Biology Technology:International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases 2International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases 3Boehringer Laboratories, Inc. Announces Live Surgery Using Innovative System to Calibrate Sleeve Gastrectomy 2Documentary Film that Follows Singularity University Students as They Change the World Launches its IndieGoGo Fundraising Campaign 2Excitonic dark states shed light on TMDC atomic layers 2Excitonic dark states shed light on TMDC atomic layers 3
... Aug. 24 Advanced Instruments has introduced a next-generation Web ... purchasing osmometers, cryoscopes, and microbiological laboratory instruments. The site, ... , was developed from the perspective of the Web ... scientific materials, and technical support. , , ...
... , BASKING RIDGE, N.J., Aug. 24 ... the development of antithrombotic therapeutic aptamers with active control ... the first Phase I study of a subcutaneous administration ... a double-blind, randomized, placebo-controlled, single ascending dose study to ...
... , SAN DIEGO, Aug. 24 ... announced that Mark Booth has joined the Company as Chief ... commercial and business development experience to Orexigen. Most recently ... where he presided over the commercial, medical and scientific affairs, ...
Cached Biology Technology:Advanced Instruments Introduces Next-Generation Web Site 2Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System 2Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2
(Date:9/15/2014)... researchers have found "the most famous wheat gene," a ... to transfer valuable genes from other plants ... to develop wheat varieties with the disease- and pest-resistance ... tools that can reduce crop losses and pesticide use ... Genetically Modified Organisms, or GMOs., "The real exciting part ...
(Date:9/15/2014)... of Science and Technology in Society in the College ... has won a 2014 National Science Foundation Faculty Early ... of creating a global nuclear emergency response plan. , ... Plant in March 2011 was a turning point in ... Three of the plant,s six nuclear reactors melted down ...
(Date:9/15/2014)... affect hearing and cognitive function may play roles in ... perceive rhythm, pitch, timbre, tone durations, and formal structure ... article explain that extremes in musical aptitude (extreme ... majority of individuals having moderate aptitude. , "This is ... several underlying genes, and it is influenced to varying ...
Breaking Biology News(10 mins):WSU researchers find 'most famous wheat gene' 2'Nuclear disasters don't respect national boundaries' 2
... at the Hebrew University of Jerusalem that details the skeletal ... and humans. The book,Micro-Tomorgrphic Atlas of the Mouse Skeleton, ... Laboratory consisting of Prof. Itai Bab, head of the laboratory; ... the writing of the book was Dr. Ralph Mller of ...
... (October 9, 2007) -- When its time for moose ... head to where it is safest from predators ... by the Wildlife Conservation Society. Published in the ... moose avoid predation of their calves by grizzly bears ...
... of North America to observe lower testosterone levels among ... study reveals that even married men who are considered ... testosterone levels than single, unmarried men. In ... (University of Nevada, Las Vegas), Peter T. Ellison (Harvard ...
Cached Biology News:Of mice and men: similarities between skeletons of both 2Study finds that even aloof husbands have lower testosterone levels than unmarried men 2
... Extraction Software reads and processes ... prepare microarray data for analysis. ... one 1-year license for ... accounts ,one CD-ROM containing Feature ...
Denhardt's Solution is a mixture of blocking agents used in membrane-based hybridization protocols. The solution contains 1% Ficoll (type 400) 1% polyvinylpyrrolidone and 1% bovine serum albumin. Ste...
... reads and processes raw microarray ... data for analysis. ,Package contains: ... license for Feature Extraction valid ... one CD-ROM containing Feature ...
... The AquaMax DW4 liquid handling system ... thorough washing all in one instrument. The ... for dispensing and plate washing96-, 384- and ... microplate washing. AquaMax DW4 has been optimized ...
Biology Products: